Sphere No.46 (Mar 2019)

Sphere #46 2019 10 Chi-Med goes GLOBAL Cover story Chi-Med is celebrating the approval of its colorectal cancer- fighting drug, Elunate®, in what will quickly become the world’s biggest cancer care market: China. The company is continuing to grow, ready to join the ranks of global Big Pharma, with big plans to expand sales, manufacturing, clinical testing capability and its portfolio of life-saving drugs.